Calamos Advisors LLC increased its position in Aetna Inc. (NYSE:AET) by 0.0% during the second quarter, Holdings Channel reports. The fund owned 62,960 shares of the company’s stock after buying an additional 23 shares during the period. Calamos Advisors LLC’s holdings in Aetna were worth $7,689,000 as of its most recent SEC filing.
A number of other large investors also recently made changes to their positions in AET. Hartford Financial Management Inc. raised its position in shares of Aetna by 304.8% in the second quarter. Hartford Financial Management Inc. now owns 850 shares of the company’s stock worth $101,000 after buying an additional 640 shares during the period. FirstMerit Bank N A Trustee acquired a new position in shares of Aetna during the second quarter worth approximately $200,000. Genesee Valley Trust Co. acquired a new position in shares of Aetna during the second quarter worth approximately $203,000. Pennsylvania Trust Co acquired a new position in shares of Aetna during the second quarter worth approximately $221,000. Finally, Atria Investments LLC acquired a new position in shares of Aetna during the second quarter worth approximately $222,000. 91.95% of the stock is owned by hedge funds and other institutional investors.
Aetna Inc. (NYSE:AET) traded up 0.37% during trading on Friday, reaching $115.45. The company had a trading volume of 1,839,122 shares. Aetna Inc. has a 12-month low of $92.42 and a 12-month high of $123.57. The firm has a market capitalization of $40.50 billion, a PE ratio of 16.92 and a beta of 0.62. The firm’s 50 day moving average price is $116.86 and its 200 day moving average price is $115.71.
Aetna (NYSE:AET) last released its quarterly earnings results on Tuesday, August 2nd. The company reported $2.21 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.12 by $0.09. The business earned $15.95 billion during the quarter, compared to analysts’ expectations of $15.69 billion. Aetna had a return on equity of 16.44% and a net margin of 3.89%. The firm’s revenue for the quarter was up 4.7% compared to the same quarter last year. During the same period last year, the firm posted $2.05 EPS. Analysts anticipate that Aetna Inc. will post $8.05 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Thursday, October 13th will be issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 0.87%. Aetna’s payout ratio is currently 14.73%.
A number of research analysts have recently commented on the company. Wells Fargo & Co. reiterated a “buy” rating on shares of Aetna in a report on Thursday, June 2nd. Credit Suisse Group AG reiterated a “hold” rating and set a $120.00 price target on shares of Aetna in a report on Wednesday, August 3rd. Leerink Swann reiterated a “buy” rating and set a $135.00 price target on shares of Aetna in a report on Thursday, August 4th. Morgan Stanley reiterated a “buy” rating on shares of Aetna in a report on Tuesday, June 14th. Finally, FBR & Co restated a “hold” rating and issued a $135.00 target price on shares of Aetna in a research note on Thursday, August 4th. Seven investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $132.79.
In other Aetna news, Director Jeffrey E. Garten sold 7,100 shares of Aetna stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $116.51, for a total value of $827,221.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Shawn M. Guertin sold 45,328 shares of Aetna stock in a transaction on Tuesday, August 23rd. The shares were sold at an average price of $120.21, for a total value of $5,448,878.88. Following the completion of the transaction, the insider now directly owns 44,883 shares of the company’s stock, valued at $5,395,385.43. The disclosure for this sale can be found here. 0.90% of the stock is owned by company insiders.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.